Hikari Power’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-17,820
| Closed | -$961K | – | 53 |
|
|
2025
Q4 | $961K | Sell |
17,820
-12,000
| -40% | -$577K | 0.08% | 46 |
|
|
2025
Q3 | $1.34M | Hold |
29,820
| – | – | 0.11% | 45 |
|
|
2025
Q2 | $1.38M | Hold |
29,820
| – | – | 0.11% | 45 |
|
|
2025
Q1 | $1.82M | Hold |
29,820
| – | – | 0.14% | 42 |
|
|
2024
Q4 | $1.69M | Hold |
29,820
| – | – | 0.15% | 46 |
|
|
2024
Q3 | $1.54M | Hold |
29,820
| – | – | 0.13% | 48 |
|
|
2024
Q2 | $1.24M | Hold |
29,820
| – | – | 0.11% | 48 |
|
|
2024
Q1 | $1.62M | Sell |
29,820
-7,460
| -20% | -$380K | 0.14% | 46 |
|
|
2023
Q4 | $1.91M | Hold |
37,280
| – | – | 0.18% | 45 |
|
|
2023
Q3 | $2.16M | Hold |
37,280
| – | – | 0.21% | 43 |
|
|
2023
Q2 | $2.38M | Hold |
37,280
| – | – | 0.23% | 43 |
|
|
2023
Q1 | $2.58M | Hold |
37,280
| – | – | 0.26% | 39 |
|
|
2022
Q4 | $2.68M | Hold |
37,280
| – | – | 0.26% | 39 |
|
|
2022
Q3 | $2.65M | Hold |
37,280
| – | – | 0.3% | 39 |
|
|
2022
Q2 | $2.87M | Hold |
37,280
| – | – | 0.31% | 38 |
|
|
2022
Q1 | $2.72M | Hold |
37,280
| – | – | 0.24% | 39 |
|
|
2021
Q4 | $2.32M | Buy |
37,280
+10,830
| +41% | +$635K | 0.22% | 40 |
|
|
2021
Q3 | $1.56M | Buy |
26,450
+7,410
| +39% | +$488K | 0.16% | 46 |
|
|
2021
Q2 | $1.27M | Buy |
19,040
+7,760
| +69% | +$506K | 0.13% | 48 |
|
|
2021
Q1 | $712K | Buy |
11,280
+3,820
| +51% | +$238K | 0.08% | 52 |
|
|
2020
Q4 | $463K | Buy |
+7,460
| New | +$459K | 0.05% | 56 |
|
|
2019
Q2 | – | Sell |
-62,080
| Closed | -$2.96M | – | 121 |
|
|
2019
Q1 | $2.96M | Hold |
62,080
| – | – | 0.31% | 53 |
|
|
2018
Q4 | $3.23M | Hold |
62,080
| – | – | 0.36% | 47 |
|
|
2018
Q3 | $3.85M | Hold |
62,080
| – | – | 0.39% | 47 |
|
|
2018
Q2 | $3.44M | Sell |
62,080
-15,520
| -20% | -$838K | 0.38% | 47 |
|
|
2018
Q1 | $4.91M | Hold |
77,600
| – | – | 0.58% | 35 |
|
|
2017
Q4 | $4.75M | Sell |
77,600
-7,200
| -8% | -$450K | 0.56% | 34 |
|
|
2017
Q3 | $5.41M | Buy |
84,800
+16,100
| +23% | +$940K | 0.7% | 32 |
|
|
2017
Q2 | $3.83M | Hold |
68,700
| – | – | 0.52% | 37 |
|
|
2017
Q1 | $3.74M | Hold |
68,700
| – | – | 0.53% | 32 |
|
|
2016
Q4 | $4.01M | Buy |
68,700
+29,100
| +73% | +$1.59M | 0.57% | 33 |
|
|
2016
Q3 | $2.13M | Buy |
39,600
+17,500
| +79% | +$1.12M | 0.25% | 51 |
|
|
2016
Q2 | $1.63M | Buy |
+22,100
| New | +$1.56M | 0.19% | 53 |
|
Other funds holding BMY
VCM
VPM
Hikari Power's BMY Position: Q1 2026 in Review
Hikari Power sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 17,820 shares — an estimated $961K sold.
Hikari Power first reported a position in BMY in Q2 2016 and held it in 33 quarters. The position peaked at $5.41M in Q3 2017. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Hikari Power reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Hikari Power sold 17,820 Bristol-Myers Squibb shares in Q1 2026, an estimated $961K.
- Hikari Power first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 33 quarters.
- Hikari Power's Bristol-Myers Squibb position peaked at $5.41M in Q3 2017.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Hikari Power's 13F filing for Q1 2026, filed 30 Apr 2026.